ATR vs. MRNA: A Head-to-Head Stock Comparison

Updated on August 30, 2025

Here’s a clear look at ATR and MRNA, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

Symbol	ATR	MRNA
Company Name	AptarGroup, Inc.	Moderna, Inc.
Country	United States	United States
GICS Sector	Materials	Health Care
GICS Industry	Containers & Packaging	Biotechnology
Market Capitalization	9.19 billion USD	9.77 billion USD
Exchange	NYSE	NasdaqGS
Listing Date	April 23, 1993	December 7, 2018
Security Type	Common Stock	Common Stock

Historical Performance

This chart compares the performance of ATR and MRNA by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

ATR vs. MRNA: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

Symbol	ATR	MRNA
5-Day Price Return	-0.85%	-4.27%
13-Week Price Return	-11.84%	-6.20%
26-Week Price Return	-4.72%	-29.36%
52-Week Price Return	-7.14%	-69.26%
Month-to-Date Return	-11.26%	-15.09%
Year-to-Date Return	-11.24%	-39.63%
10-Day Avg. Volume	0.51M	9.33M
3-Month Avg. Volume	0.40M	10.18M
3-Month Volatility	26.53%	51.61%
Beta	0.57	2.03

Profitability

Return on Equity (TTM)

ATR

15.28%

Containers & Packaging Industry

Max: 41.66%
Q3: 20.76%
Median: 14.35%
Q1: 6.55%
Min: 3.64%

ATR’s Return on Equity of 15.28% is on par with the norm for the Containers & Packaging industry, indicating its profitability relative to shareholder equity is typical for the sector.

MRNA

-27.46%

Biotechnology Industry

Max: 77.14%
Q3: 10.76%
Median: -20.08%
Q1: -42.71%
Min: -119.20%

MRNA has a negative Return on Equity of -27.46%. This indicates the company is generating a loss for its shareholders, which can be a result of unprofitability or negative shareholder equity and is often a sign of financial distress.

ATR vs. MRNA: A comparison of their Return on Equity (TTM) against their respective Containers & Packaging and Biotechnology industry benchmarks.

Net Profit Margin (TTM)

ATR

10.84%

Containers & Packaging Industry

Max: 11.61%
Q3: 8.17%
Median: 4.91%
Q1: 4.20%
Min: 0.08%

A Net Profit Margin of 10.84% places ATR in the upper quartile for the Containers & Packaging industry, signifying strong profitability and more effective cost management than most of its peers.

MRNA

-94.31%

Biotechnology Industry

Max: 59.44%
Q3: 16.21%
Median: -11.49%
Q1: -167.42%
Min: -409.07%

MRNA has a negative Net Profit Margin of -94.31%, indicating the company is operating at a net loss as its expenses exceeded its revenues.

ATR vs. MRNA: A comparison of their Net Profit Margin (TTM) against their respective Containers & Packaging and Biotechnology industry benchmarks.

Operating Profit Margin (TTM)

ATR

14.30%

Containers & Packaging Industry

Max: 22.03%
Q3: 13.17%
Median: 8.87%
Q1: 6.86%
Min: 0.07%

An Operating Profit Margin of 14.30% places ATR in the upper quartile for the Containers & Packaging industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.

MRNA

-106.34%

Biotechnology Industry

Max: 60.62%
Q3: 20.76%
Median: -12.41%
Q1: -181.14%
Min: -482.02%

MRNA has a negative Operating Profit Margin of -106.34%. This signifies the company is unprofitable at the operational level, as its core business expenses exceed its revenue.

ATR vs. MRNA: A comparison of their Operating Profit Margin (TTM) against their respective Containers & Packaging and Biotechnology industry benchmarks.

Profitability at a Glance

Symbol	ATR	MRNA
Return on Equity (TTM)	15.28%	-27.46%
Return on Assets (TTM)	8.49%	-21.24%
Net Profit Margin (TTM)	10.84%	-94.31%
Operating Profit Margin (TTM)	14.30%	-106.34%
Gross Profit Margin (TTM)	38.32%	68.32%

Financial Strength

Current Ratio (MRQ)

ATR

1.21

Containers & Packaging Industry

Max: 2.13
Q3: 1.57
Median: 1.27
Q1: 1.13
Min: 0.58

ATR’s Current Ratio of 1.21 aligns with the median group of the Containers & Packaging industry, indicating that its short-term liquidity is in line with its sector peers.

MRNA

3.93

Biotechnology Industry

Max: 19.31
Q3: 9.38
Median: 4.54
Q1: 2.45
Min: 0.76

MRNA’s Current Ratio of 3.93 aligns with the median group of the Biotechnology industry, indicating that its short-term liquidity is in line with its sector peers.

ATR vs. MRNA: A comparison of their Current Ratio (MRQ) against their respective Containers & Packaging and Biotechnology industry benchmarks.

Debt-to-Equity Ratio (MRQ)

ATR

0.40

Containers & Packaging Industry

Max: 4.50
Q3: 2.23
Median: 1.22
Q1: 0.54
Min: 0.23

Falling into the lower quartile for the Containers & Packaging industry, ATR’s Debt-to-Equity Ratio of 0.40 points to a conservative financing strategy. This results in lower financial risk but potentially limits strategic investments compared to more leveraged competitors.

MRNA

0.01

Biotechnology Industry

Max: 1.35
Q3: 0.64
Median: 0.09
Q1: 0.00
Min: 0.00

MRNA’s Debt-to-Equity Ratio of 0.01 is typical for the Biotechnology industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.

ATR vs. MRNA: A comparison of their Debt-to-Equity Ratio (MRQ) against their respective Containers & Packaging and Biotechnology industry benchmarks.

Interest Coverage Ratio (TTM)

ATR

16.66

Containers & Packaging Industry

Max: 13.16
Q3: 8.10
Median: 3.61
Q1: 2.94
Min: 1.06

With an Interest Coverage Ratio of 16.66, ATR demonstrates a superior capacity to service its debt, placing it well above the typical range for the Containers & Packaging industry. This stems from either robust earnings or a conservative debt load.

MRNA

Biotechnology Industry

Max: 72.37
Q3: 1.91
Median: -7.81
Q1: -63.90
Min: -153.80

Interest Coverage Ratio data for MRNA is currently unavailable.

ATR vs. MRNA: A comparison of their Interest Coverage Ratio (TTM) against their respective Containers & Packaging and Biotechnology industry benchmarks.

Financial Strength at a Glance

Symbol	ATR	MRNA
Current Ratio (MRQ)	1.21	3.93
Quick Ratio (MRQ)	0.83	3.59
Debt-to-Equity Ratio (MRQ)	0.40	0.01
Interest Coverage Ratio (TTM)	16.66	--

Growth

Revenue Growth

ATR vs. MRNA: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

ATR vs. MRNA: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

ATR

1.30%

Containers & Packaging Industry

Max: 7.37%
Q3: 4.07%
Median: 3.33%
Q1: 1.72%
Min: 0.00%

ATR’s Dividend Yield of 1.30% is in the lower quartile for the Containers & Packaging industry. This suggests the company’s strategy likely favors retaining earnings for growth over providing a high dividend income.

MRNA

0.00%

Biotechnology Industry

Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

MRNA currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

ATR vs. MRNA: A comparison of their Dividend Yield (TTM) against their respective Containers & Packaging and Biotechnology industry benchmarks.

Dividend Payout Ratio (TTM)

ATR

30.51%

Containers & Packaging Industry

Max: 221.20%
Q3: 119.52%
Median: 58.05%
Q1: 28.91%
Min: 0.00%

ATR’s Dividend Payout Ratio of 30.51% is within the typical range for the Containers & Packaging industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

MRNA

0.00%

Biotechnology Industry

Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

MRNA has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

ATR vs. MRNA: A comparison of their Dividend Payout Ratio (TTM) against their respective Containers & Packaging and Biotechnology industry benchmarks.

Dividend at a Glance

Symbol	ATR	MRNA
Dividend Yield (TTM)	1.30%	0.00%
Dividend Payout Ratio (TTM)	30.51%	0.00%

Valuation

Price-to-Earnings Ratio (TTM)

ATR

23.49

Containers & Packaging Industry

Max: 35.98
Q3: 27.87
Median: 16.15
Q1: 14.38
Min: 8.20

ATR’s P/E Ratio of 23.49 is within the middle range for the Containers & Packaging industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

MRNA

Biotechnology Industry

Max: 60.14
Q3: 38.17
Median: 29.01
Q1: 15.12
Min: 0.00

P/E Ratio data for MRNA is currently unavailable.

ATR vs. MRNA: A comparison of their Price-to-Earnings Ratio (TTM) against their respective Containers & Packaging and Biotechnology industry benchmarks.

Price-to-Sales Ratio (TTM)

ATR

2.55

Containers & Packaging Industry

Max: 2.91
Q3: 1.67
Median: 0.83
Q1: 0.64
Min: 0.30

ATR’s P/S Ratio of 2.55 is in the upper echelon for the Containers & Packaging industry. This means the company is valued richly on its revenue stream compared to its peers, suggesting the stock is priced for a high level of future performance.

MRNA

3.39

Biotechnology Industry

Max: 76.98
Q3: 36.53
Median: 9.49
Q1: 4.49
Min: 0.00

In the lower quartile for the Biotechnology industry, MRNA’s P/S Ratio of 3.39 indicates its revenue is valued more conservatively than most of its peers. This could present a compelling opportunity if the market has overlooked its sales-generating capabilities.

ATR vs. MRNA: A comparison of their Price-to-Sales Ratio (TTM) against their respective Containers & Packaging and Biotechnology industry benchmarks.

Price-to-Book Ratio (MRQ)

ATR

3.83

Containers & Packaging Industry

Max: 5.28
Q3: 3.30
Median: 2.35
Q1: 1.57
Min: 0.89

ATR’s P/B Ratio of 3.83 is in the upper tier for the Containers & Packaging industry. This indicates that investors are paying a premium relative to the company’s net assets, a valuation that hinges on its ability to generate superior profits.

MRNA

1.14

Biotechnology Industry

Max: 20.53
Q3: 9.76
Median: 4.77
Q1: 2.49
Min: 0.59

MRNA’s P/B Ratio of 1.14 is in the lower quartile for the Biotechnology industry. From a value investing perspective, this is favorable, as it suggests the stock is trading at a discount to its net asset value and may offer a greater margin of safety.

ATR vs. MRNA: A comparison of their Price-to-Book Ratio (MRQ) against their respective Containers & Packaging and Biotechnology industry benchmarks.

Valuation at a Glance

Symbol	ATR	MRNA
Price-to-Earnings Ratio (TTM)	23.49	--
Price-to-Sales Ratio (TTM)	2.55	3.39
Price-to-Book Ratio (MRQ)	3.83	1.14
Price-to-Free Cash Flow Ratio (TTM)	26.92	34.41